InvestorsHub Logo
Followers 11
Posts 600
Boards Moderated 0
Alias Born 12/13/2016

Re: Irie9 post# 3135

Wednesday, 03/28/2018 9:46:31 AM

Wednesday, March 28, 2018 9:46:31 AM

Post# of 7474
Hi Irie,

I will post your questions and address each individually.

Q: "There has been talk of CNBX patents and pending patents adding massive value to the company. Have they talked about how the patents will add value?"

A: The new patents are for personalized treatments. The main drive (and added value) of obtaining the new patents are for patenting methods of testing that will allow for personalizing which cannabinoids or combinations of cannabinoids are effective in individual patients.

You will have blood drawn and medication created to treat your exact issues, not just be prescribed a catch-all prescription or treatment. An area to compare this to is the treatment of allergies. Instead of just prescribing prescription level Claritin, allergists draw blood and create serums specific to a patients allergies, give injections over time, raising the level of the allergens being treated, and give a personalized instead of generic treatment.

Q: "Has there been any interest from external companies or markets in any of the patents?"

A: YES!!! Personalized cancer treatments have been the goal of many companies, but particularly of major hospitals that partner with manufacturers to create their own studies and find ways to personalize treatment.

Mega Hospitals are the new big pharma. They partner with their governments to perform studies and create treatments and then sell the products to companies like Merck, etc to distribute. Studies like these help fund the hospitals and in turn fund further studies of other ailments. For a review of just such studies, see the link below, which is a hospital/multi-government partnership:

https://clinicaltrials.gov/ct2/show/NCT02359123

I am in a study like this myself. I have been being treated for allergies in this way the last couple years, and a lot of my costs have recently been picked up in a partnership between the manufacturers and hospital because they want to use my results in their studies. My agreement is between my hospital, my medical provider (allergist), and the manufacturer of the products they are giving me (ie, like a CNBX). Each shot I receive would have cost me over $ 1,000 at 13 shots a month, but instead, I am paying for just the office visits, and even they are greatly reduced to around $ 10 every 4 months.

Q: "Will they try to develop pharmaceuticals themselves?" Cannabics is continually developing new pharmaceuticals, in addition to the ones they already have. Serums and pills both.

Q: "I have heard of multiple time release cbd capsules on the market. Do they have a patent for their time release capsule?"

A: If they are on the market, my guess is they have a patent or patent pending. Cannabics first long release pills have been on the market since late 2014 and have all been under patent.

If you could, please provide me links to these other time released capsules and I will review them.

Remember that Cannabics does not put their name on their pills, so products you see like the WANA Brands, Wana Caps, etc are actually Cannabics products with a different name/branding.

I do not know of any long release pill manufacturer that has had the track record Cannabics (and Rambam Hospital in Israel where they test their products) have had in the long release pill sector, but I would be happy to look and compare if you can provide links.

Q: "What is the profit catalyst that would drive this s/p to $20 as you’ve stated in the past?"

A: While I typically talk research and findings instead of share prices, my statement about CNBX being anticipated to go to around $ 20 or more once the US and International patents are in for personalization is based on what other products went to when their patents came in.

The stock price of GWPH for example, which uses a 4-hour oral spray instead of 12-hour long release pill, skyrocketed, and their stock closed yesterday at $ 110 pps. With being a 4-hour spray instead of a 12-hour pill, their product is inferior in my opinion due to the workplace and acceptance/convenience implications I have stated in previous posts, but their stock skyrocketed just the same.

Get with me if you have further questions. I have pasted one of the links below that discusses personalization.

Take care, Jim

https://www.prnewswire.com/news-releases/cannabics-pharmaceuticals-files-an-international-patent-application-on-methods-for-testing-and-predicting-therapeutic-effectiveness-of-cannabinoids-for-cancer-patients-667671863.html